S
Suyash Prasad
Researcher at Astellas Pharma
Publications - 37
Citations - 1129
Suyash Prasad is an academic researcher from Astellas Pharma. The author has contributed to research in topics: X-linked myotubular myopathy & Medicine. The author has an hindex of 15, co-authored 32 publications receiving 957 citations. Previous affiliations of Suyash Prasad include Genzyme & BioMarin Pharmaceutical.
Papers
More filters
Journal ArticleDOI
Phenylketonuria Scientific Review Conference: state of the science and future research needs.
Kathryn M. Camp,Melissa A. Parisi,Phyllis B. Acosta,Gerard T. Berry,Deborah A. Bilder,Nenad Blau,Nenad Blau,Olaf Bodamer,Jeffrey P. Brosco,Christine Brown,Alberto Burlina,Barbara K. Burton,Christine Chang,Paul M. Coates,Amy Cunningham,Steven F. Dobrowolski,John H. Ferguson,Thomas D. Franklin,Dianne M. Frazier,Dorothy K. Grange,Carol L. Greene,Stephen C. Groft,Cary O. Harding,R. Rodney Howell,Kathleen Huntington,Henrietta D. Hyatt-Knorr,Indira Jevaji,Harvey L. Levy,Uta Lichter-Konecki,Mary Lou Lindegren,Michele A. Lloyd-Puryear,Kimberlee Michals Matalon,Anita MacDonald,Melissa L McPheeters,John J. Mitchell,Shideh Mofidi,Kathryn D. Moseley,Christine M. Mueller,Andrew E. Mulberg,Lata S. Nerurkar,Beth N. Ogata,Anne R. Pariser,Suyash Prasad,Gabriella Pridjian,Sonja A. Rasmussen,Uma M. Reddy,Frances Rohr,Rani H. Singh,Sandra Sirrs,Stephanie E. Stremer,Danilo A. Tagle,Susan Thompson,Tiina K. Urv,Jeanine Utz,Francjan J. van Spronsen,Jerry Vockley,Susan E. Waisbren,Linda S. Weglicki,Desirée A. White,Chester B. Whitley,Benjamin S. Wilfond,Steven Yannicelli,Justin M. Young +62 more
TL;DR: A coordinated approach to PKU treatment improves long-term outcomes for those with PKU and facilitates the conduct of research to improve diagnosis and treatment, and there are significant gaps in predicting response to treatment.
Journal ArticleDOI
A common founder for the 35delg gjb2 gene mutation in connexin 26 hearing impairment
L. Van Laer,Paul Coucke,Robert F. Mueller,Goele Caethoven,Kris Flothmann,Suyash Prasad,G P Chamberlin,Mark J. Houseman,Graham R. Taylor,C M Van De Heyning,Erik Fransén,J S Rowland,Robert A. Cucci,Richard J.H. Smith,G. Van Camp +14 more
TL;DR: Evidence is reported that the high frequency of this allelic variant is the result of a founder effect rather than a mutational hot spot in GJB2, which was the prevailing hypothesis.
Journal ArticleDOI
Pompe disease: Design, methodology, and early findings from the Pompe Registry
Barry J. Byrne,Priya S. Kishnani,Laura E. Case,Luciano Merlini,Wolfgang Müller-Felber,Suyash Prasad,Ans T. van der Ploeg +6 more
TL;DR: As the largest dataset on Pompe disease to date, the Pompe Registry will serve to improve recognition of the disease, enhance understanding of the variable disease course, and offer insights into treated and untreated disease course.
Journal ArticleDOI
Systematic Review and Meta-Analysis of Neuropsychiatric Symptoms and Executive Functioning in Adults With Phenylketonuria
Deborah A. Bilder,J. Kay Noel,Erin R. Baker,William Irish,Yinpu Chen,Markus Merilainen,Suyash Prasad,Barbara J. Winslow +7 more
TL;DR: Findings support lifelong maintenance of low blood Phe, which is associated with improved neurological performance and increased prevalence of neuropsychiatric symptoms and executive functioning deficits in adults with phenylketonuria.
Journal ArticleDOI
Skeletal Muscle Pathology in X-Linked Myotubular Myopathy: Review With Cross-Species Comparisons
Michael W. Lawlor,Alan H. Beggs,Ana Buj-Bello,Martin K. Childers,James J. Dowling,Emma James,Hui Meng,Steven A. Moore,Suyash Prasad,Benedikt Schoser,Caroline Sewry +10 more
TL;DR: This review summarizes the published animal models ofXLMTM, including those of zebrafish, mice, and dogs, with a focus on their pathological features as compared to those seen in human XLMTM patients.